Jinlu Dai

5.8k total citations
58 papers, 4.5k citations indexed

About

Jinlu Dai is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinlu Dai has authored 58 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 32 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinlu Dai's work include Bone health and treatments (24 papers), Prostate Cancer Treatment and Research (18 papers) and Bone Metabolism and Diseases (12 papers). Jinlu Dai is often cited by papers focused on Bone health and treatments (24 papers), Prostate Cancer Treatment and Research (18 papers) and Bone Metabolism and Diseases (12 papers). Jinlu Dai collaborates with scholars based in United States, China and Japan. Jinlu Dai's co-authors include Evan T. Keller, Zhi Yao, Jill M. Keller, Atsushi Mizokami, Yi Lü, Christopher L. Hall, Russell S. Taichman, Kenneth J. Pienta, Laurie K. McCauley and June Escara‐Wilke and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Jinlu Dai

57 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jinlu Dai 2.4k 2.1k 1.2k 856 677 58 4.5k
Sonja Loges 1.9k 0.8× 2.7k 1.3× 630 0.5× 1.4k 1.7× 926 1.4× 98 5.0k
Juan Juan Yin 2.1k 0.9× 2.5k 1.1× 804 0.7× 823 1.0× 337 0.5× 71 4.2k
Sandra S. McAllister 2.8k 1.2× 2.3k 1.1× 1.1k 0.9× 1.2k 1.3× 1.1k 1.7× 46 5.1k
Eric A. Severson 1.5k 0.6× 2.0k 0.9× 1.3k 1.1× 1.2k 1.3× 861 1.3× 127 4.3k
Sandra Ryeom 993 0.4× 2.3k 1.1× 764 0.7× 742 0.9× 631 0.9× 71 4.4k
Mario A. Anzano 1.5k 0.6× 3.8k 1.8× 552 0.5× 758 0.9× 448 0.7× 41 6.0k
Lukas J.A.C. Hawinkels 2.1k 0.9× 1.9k 0.9× 590 0.5× 895 1.0× 1.6k 2.4× 99 4.8k
Jaume Mora 1.2k 0.5× 3.1k 1.4× 715 0.6× 1.0k 1.2× 394 0.6× 216 5.5k
Dennis K. Watson 1.3k 0.5× 3.6k 1.7× 776 0.7× 1.0k 1.2× 904 1.3× 106 5.8k
Carlton R. Cooper 1.4k 0.6× 1.0k 0.5× 595 0.5× 415 0.5× 553 0.8× 40 2.7k

Countries citing papers authored by Jinlu Dai

Since Specialization
Citations

This map shows the geographic impact of Jinlu Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinlu Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinlu Dai more than expected).

Fields of papers citing papers by Jinlu Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinlu Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinlu Dai. The network helps show where Jinlu Dai may publish in the future.

Co-authorship network of co-authors of Jinlu Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Jinlu Dai. A scholar is included among the top collaborators of Jinlu Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinlu Dai. Jinlu Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Robinson, Tyler, June Escara‐Wilke, Jinlu Dai, Johann Zimmermann, & Evan T. Keller. (2023). A CXCR4 inhibitor (balixafortide) enhances docetaxel‐mediated antitumor activity in a murine model of prostate cancer bone metastasis. The Prostate. 83(13). 1247–1254. 9 indexed citations
3.
Shelley, Greg, et al.. (2020). Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells. Molecular Cancer Research. 18(9). 1290–1301. 33 indexed citations
4.
Osawa, Takahiro, et al.. (2019). Macrofluidic recirculating model of skeletal metastasis. Scientific Reports. 9(1). 14979–14979. 10 indexed citations
5.
Jiang, Yuan, Jinlu Dai, Zhi Yao, Greg Shelley, & Evan T. Keller. (2017). Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression. Molecular Cancer Research. 15(7). 875–883. 27 indexed citations
6.
Zhang, Mi, Jinlu Dai, Jill M. Keller, et al.. (2017). Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance. Molecular Cancer Research. 15(4). 457–466. 10 indexed citations
7.
Cui, Di, Jinlu Dai, Jill M. Keller, et al.. (2015). Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer. Clinical Cancer Research. 21(20). 4619–4629. 80 indexed citations
8.
Sottnik, Joseph L., Jinlu Dai, Honglai Zhang, Brittany Campbell, & Evan T. Keller. (2015). Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases. Cancer Research. 75(11). 2151–2158. 114 indexed citations
9.
Jiang, Yuan, Jinlu Dai, Honglai Zhang, et al.. (2013). Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone. Molecular Cancer Research. 11(12). 1597–1610. 26 indexed citations
10.
Dai, Jinlu, Honglai Zhang, Jill M. Keller, et al.. (2013). Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions. Clinical Cancer Research. 20(3). 617–630. 79 indexed citations
11.
Jung, Younghun, Yusuke Shiozawa, Jingcheng Wang, et al.. (2012). Prevalence of Prostate Cancer Metastases after Intravenous Inoculation Provides Clues into the Molecular Basis of Dormancy in the Bone Marrow Microenvironment. Neoplasia. 14(5). 429–439. 50 indexed citations
12.
Liao, Chuanhong, Jinlu Dai, Evan T. Keller, et al.. (2011). Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells. Clinical Cancer Research. 17(10). 3112–3122. 28 indexed citations
13.
Mizokami, Atsushi, Kouji Izumi, Kazutaka Narimoto, et al.. (2009). CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer. The Prostate. 70(1). 48–60. 27 indexed citations
14.
Dai, Jinlu, Christopher L. Hall, June Escara‐Wilke, et al.. (2008). Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms. Cancer Research. 68(14). 5785–5794. 119 indexed citations
15.
Yu, Chunyan, Zhi Yao, Jinlu Dai, et al.. (2007). Aldehyde dehydrogenase is a marker of prostate cancer stem cell-like cells in cell lines. Cancer Research. 67. 1300–1300. 1 indexed citations
16.
Park, Bae-Keun, Honglai Zhang, Qinghua Zeng, et al.. (2006). NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nature Medicine. 13(1). 62–69. 277 indexed citations
17.
Artz, Andrew, Dean Fergusson, Paul J. Drinka, et al.. (2004). Mechanisms of Unexplained Anemia in the Nursing Home. Journal of the American Geriatrics Society. 52(3). 423–427. 80 indexed citations
18.
Zhang, Jian, Jinlu Dai, Yinghua Qi, et al.. (2001). Osteoprotegerin inhibits prostate cancer–induced osteoclastogenesis and prevents prostate tumor growth in the bone. Journal of Clinical Investigation. 107(10). 1235–1244. 374 indexed citations
19.
Lin, Din‐Lii, Catherine P. Tarnowski, Jinlu Dai, et al.. (2001). Bone metastatic LNCaP‐derivative C4‐2B prostate cancer cell line mineralizes in vitro. The Prostate. 47(3). 212–221. 128 indexed citations
20.
Dai, Jinlu, Din‐Lii Lin, Jian Zhang, et al.. (2000). Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. Journal of Clinical Investigation. 106(7). 887–895. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonja Loges Breakdown of academic impact, for papers by Juan Juan Yin Breakdown of academic impact, for papers by Sandra S. McAllister Breakdown of academic impact, for papers by Eric A. Severson Breakdown of academic impact, for papers by Sandra Ryeom Breakdown of academic impact, for papers by Mario A. Anzano Breakdown of academic impact, for papers by Lukas J.A.C. Hawinkels Breakdown of academic impact, for papers by Jaume Mora Breakdown of academic impact, for papers by Dennis K. Watson Breakdown of academic impact, for papers by Carlton R. Cooper
Rankless by CCL
2026